Tag Archives: CONN

Top 10 Medical Stocks To Invest In 2019

The past two-plus decades have yielded some incredible change in the cannabis landscape. Back in 1995, not a single U.S. state allowed marijuana to be used for medicinal or recreational purposes. Fast-forward to today, 29 states have passed broad-based medical cannabis laws. Furthermore, nine also allow adults to consume marijuana. In this span, favorability toward legalizing weed has grown from 25% in 1995 to 64% as of October 2017, according to Gallup. 

And it’s not just the U.S. that’s seen an about-face in perception toward cannabis. More than two dozen countries around the world have legalized medical cannabis for select ailments, including Mexico in June 2017. But there’s arguably no legalization that stands out as more profound than Canada’s Parliament giving the green light to Bill C-45, which is better known as the Cannabis Act.

Image source: Getty Images.

Top 10 Medical Stocks To Invest In 2019: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) will share its latest quarterly results early Tuesday. The consensus estimates call for a $0.41 in earnings per share (EPS) and $384.09 million in revenue. Shares ended last week’s trading at $41.00, in a 52-week range of $17.15 to $41.35. The consensus analyst target is $42.42.

  • [By Ethan Ryder]

    Brokerages expect Conn’s Inc (NASDAQ:CONN) to post sales of $376.86 million for the current quarter, according to Zacks. Three analysts have issued estimates for Conn’s’ earnings, with the highest sales estimate coming in at $384.13 million and the lowest estimate coming in at $369.84 million. Conn’s reported sales of $366.65 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 2.8%. The firm is scheduled to announce its next quarterly earnings report on Thursday, September 6th.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Conn’s (CONN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel Miller]

    Shares of home furnishings specialist Conn’s Inc. (NASDAQ:CONN) are falling today, down 13.7% as of 3:19 p.m. EDT, after investors digested second-quarter results that had initially sent the stock 7% higher during pre-market trading.

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Three Stocks to Watch Today: WDAY, AMZN, NKE
    Workday Inc. (Nasdaq: WDAY) leads a busy day of earnings reports Tuesday. The firm will present its quarterly report after the bell. Wall Street expects that the company will report earnings per share of $0.26 on top of $633.1 million in revenue. Amazon.com Inc. (Nasdaq: AMZN) will be generating a lot of buzz today. The e-commerce giant apparently has its eyes on the $88 billion online advertising industry. The firm plans to take direct aim at rivals Alphabet Inc. (Nasdaq: GOOGL) and Facebook Inc. (Nasdaq: FB). Amazon is very close to becoming the second company to surpass the $1 trillion threshold for market capitalization. Nike Inc. (NYSE: NKE) is making headlines the week before the NFL’s opening week starts. The sports apparel giant announced that former San Francisco quarterback Colin Kaepernick will be one of the faces of its 30th anniversary commemorations for its “Just Do It” campaign. Kaepernick has been one of the NFL’s most polarizing figures after he began kneeling during the national anthem to protest police abuse against African Americans and other social injustices. Look for earnings reports from Restoration Hardware Holdings Inc. (NYSE: RH), Casey’s General Stores Inc. (Nasdaq: CASY), Conns Inc. (Nasdaq: CONN), Caleres Inc. (NYSE: CAL), HealthEquity Inc. (NYSE: HQY), and Coupa Software Inc. (Nasdaq: COUP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 10 Medical Stocks To Invest In 2019: Ocean Power Technologies Inc.(OPTT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Ocean Power Technologies Inc (NASDAQ:OPTT) traded down 5.3% during mid-day trading on Friday . The company traded as low as $0.30 and last traded at $0.30. 818,065 shares traded hands during trading, an increase of 192% from the average session volume of 280,461 shares. The stock had previously closed at $0.32.

  • [By Logan Wallace]

    Media stories about Ocean Power Technologies (NASDAQ:OPTT) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ocean Power Technologies earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news coverage about the energy company an impact score of 43.6315011267629 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Ocean Power Technologies (NASDAQ:OPTT) last issued its quarterly earnings results on Monday, December 10th. The energy company reported ($0.21) EPS for the quarter. The business had revenue of $0.14 million for the quarter.

    TRADEMARK VIOLATION WARNING: “Ocean Power Technologies (OPTT) Sees Strong Trading Volume” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at www.tickerreport.com/banking-finance/4214323/ocean-power-technologies-optt-sees-strong-trading-volume.html.

    About Ocean Power Technologies (NASDAQ:OPTT)

Top 10 Medical Stocks To Invest In 2019: ClearOne Communications Inc.(CLRO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Akoustis Technologies (NASDAQ: CLRO) and Clearone (NASDAQ:CLRO) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

  • [By Ethan Ryder]

    Fabrinet (NASDAQ: CLRO) and Clearone (NASDAQ:CLRO) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Clearone (CLRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: Pacific Gas & Electric Co.(PCG)

Advisors’ Opinion:

  • [By Tyler Crowe, Matthew Frankel, CFP, and Neha Chamaria]

    So we asked three Motley Fool contributors to each highlight a stock that has caught the eye of billionaire hedge funds, why they are buying, and why you might want to consider doing the same. Here’s why they picked United Technologies (NYSE:UTX), PG&E (NYSE:PCG), and Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B).

  • [By Sean Williams]

    Possibly the biggest shocker of all is that David Tepper’s Appaloosa, which has a little over three dozen securities in its portfolio, was an active buyer of Northern and Central California electric and gas utility PG&E (NYSE:PCG) during the fourth quarter. Appaloosa increased its stake in the company by 62% (2.48 million shares), making it the portfolio’s fourth-largest holding.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was PG&E Corp. (NYSE: PCG) which rose about 6% to $45.08. The stock’s 52-week range is $37.30 to $71.57. Volume was nearly 13 million compared to the daily average volume of 6.8 million.

  • [By VantagePoint]

    PG&E Corporation (NYSE: PCG) has spent most of the last five weeks consolidating into a tight range, but it looks to have finally broken out on April 5. Since then the stock is up about 7 percent, and despite Friday's weakness VantagePoint's indicators are pointing to that bullish trend remaining intact. 

  • [By Chris Lange]

    PG&E Corp. (NYSE: PCG) shares made a handy gain on Tuesday after a key analyst upgraded the stock. Most of this report has to do with California wildfire liabilities from 2017, and there seems to be a clear path ahead. Overall the firm believes the worst is likely over.

Top 10 Medical Stocks To Invest In 2019: Medical Marijuana, Inc. (MJNA)

Advisors’ Opinion:

  • [By Sean Williams]

    If I were to choose two marijuana stocks right off the bat that I’d rather watch from the sidelines and never buy, it’d be medical cannabis company Medical Marijuana Inc. (NASDAQOTH:MJNA) and cannabinoid-based drug developer AXIM Biotechnologies (NASDAQOTH:AXIM). The reason they’re listed together is because Medical Marijuana Inc. owns 22.67 million shares of AXIM, which is about 40% of its outstanding share count. Their futures really are tied together.

  • [By Sean Williams]

    One company aiming to capitalize on this trend in the U.S. is Medical Marijuana Inc. (NASDAQOTH:MJNA), the first publicly traded pot stock in the United States. Medical Marijuana’s RSHO-X brand focuses on cannabidiol-based hemp oils. Cannabidiol is the non-psychoactive component of the cannabis plant known for its perceived medical benefits. Considering that even older Americans have a positive view on medical cannabis, this is the type of company and product that could do well with boomers. Perhaps not surprisingly, Medical Marijuana Inc. recorded its strongest sales month in history in August. 

  • [By George Budwell]

    Medical Marijuana (NASDAQOTH:MJNA) is only a matter of months away from its 10-year anniversary as the first publicly traded cannabis stock. Despite its elder-statesman status, however, Medical Marijuana hasn’t been kind to investors since going public. In fact, the stock is down by nearly 90% since its IPO in March of 2009.

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

Top 10 Medical Stocks To Invest In 2019: J.M. Smucker Company (SJM)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    The selling environment has been tough in recent years for most packaged foods companies, and J.M. Smucker’s (NYSE:SJM) latest operating results showed it isn’t immune to the wider challenges its segment faces. On Thursday, the owner of Jif, Crisco, and other popular consumer brands posted flat sales to end its fiscal 2018, with profits coming in below management’s targets.

  • [By Asit Sharma]

    J.M. Smucker (NYSE:SJM) closed out the fourth quarter of fiscal year 2018 in rather flat fashion, as a bird’s-eye view of revenue, pulled from the company’s earnings report issued Thursday morning, suggests:

  • [By Joseph Griffin]

    J M Smucker (NYSE:SJM)‘s stock had its “hold” rating reaffirmed by investment analysts at Barclays in a research note issued on Monday.

  • [By Ethan Ryder]

    J M Smucker (NYSE:SJM) had its price target hoisted by Credit Suisse Group from $90.00 to $95.00 in a research note issued to investors on Wednesday morning. Credit Suisse Group currently has an underperform rating on the stock.

  • [By Ethan Ryder]

    J M Smucker (NYSE:SJM) and Farmmi (NASDAQ:FAMI) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.

  • [By Joseph Griffin]

    CIBC World Markets Inc. grew its position in shares of J M Smucker Co (NYSE:SJM) by 72.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 24,839 shares of the company’s stock after buying an additional 10,452 shares during the period. CIBC World Markets Inc.’s holdings in J M Smucker were worth $2,670,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Invest In 2019: Regis Corporation(RGS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Regis Co. (NYSE:RGS) have been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $18.00.

  • [By Max Byerly]

    JPMorgan Chase & Co. reduced its position in shares of Regis Co. (NYSE:RGS) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,065,983 shares of the company’s stock after selling 44,497 shares during the quarter. JPMorgan Chase & Co. owned about 2.31% of Regis worth $16,128,000 as of its most recent SEC filing.

  • [By Dan Caplinger]

    The stock market continued moving up on Tuesday, with the S&P 500 hitting a new high at points during the session before pulling back slightly. Even though the Dow Jones Industrial Average is still well short of its record levels, market participants were pleased to see extremely strong sentiment from investors, especially among stocks of smaller companies. With the current bull market being well into its 10th year, many skeptics have looked for signs of eroding confidence, but those that have appeared recently haven’t had any lasting downward impact on stocks. Good news from several companies helped contribute to the positive mood on Wall Street. Cronos Group (NASDAQ:CRON), Medtronic (NYSE:MDT), and Regis (NYSE:RGS) were among the best performers on the day. Here’s why they did so well.

  • [By Stephan Byrd]

    Regis Co. (NYSE:RGS) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $17.50 and last traded at $17.50, with a volume of 3726 shares changing hands. The stock had previously closed at $17.43.

Top 10 Medical Stocks To Invest In 2019: Abeona Therapeutics Inc.(ABEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    HC Wainwright set a $30.00 target price on Abeona Therapeutics (NASDAQ:ABEO) in a research report report published on Monday. The firm currently has a buy rating on the biopharmaceutical company’s stock.

  • [By Ethan Ryder]

    Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) have been assigned a consensus rating of “Buy” from the thirteen ratings firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $29.44.

  • [By Shane Hupp]

    Abeona Therapeutics Inc (NASDAQ:ABEO) shares traded up 9.2% during mid-day trading on Friday . The company traded as high as $8.14 and last traded at $8.10. 657,079 shares were traded during mid-day trading, an increase of 65% from the average session volume of 399,426 shares. The stock had previously closed at $7.42.

Top 10 Medical Stocks To Invest In 2019: Johnson Controls Inc.(JCI)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Johnson Controls Inc  (NYSE:JCI)Q1 2019 Earnings Conference CallFeb. 01, 2019, 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Cowen reiterated their hold rating on shares of Johnson Controls International (NYSE:JCI) in a research note released on Friday. Cowen currently has a $32.00 price target on the stock.

  • [By Max Byerly]

    Commonwealth Equity Services LLC cut its holdings in Johnson Controls International PLC (NYSE:JCI) by 32.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 91,206 shares of the company’s stock after selling 43,598 shares during the period. Commonwealth Equity Services LLC’s holdings in Johnson Controls International were worth $2,704,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Johnson Controls International (JCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: Tupperware Brands Corporation(TUP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Twin Capital Management Inc. boosted its position in shares of Tupperware Brands Co. (NYSE:TUP) by 2.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 80,930 shares of the company’s stock after acquiring an additional 2,300 shares during the period. Twin Capital Management Inc. owned 0.16% of Tupperware Brands worth $3,338,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Tupperware Brands (NYSE: TUP) and Armstrong Flooring (NYSE:AFI) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
  • [By Stephan Byrd]

    Armstrong Flooring (NYSE: AFI) and Tupperware Brands (NYSE:TUP) are both construction companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability.

Top 10 Casino Stocks To Own Right Now

Late last year, Japan legalized casinos in the country, opening up a gaming industry that could generate as much as $30 billion a year in revenues and become the second-largest casino market in the world. As several players scout for licenses, Las Vegas Sands (NYSE: LVS) is ready to invest heavily in the region, committing to an initial investment of $10 billion. While this is a significant number, if Las Vegas Sands is able to capture a decent share in the market, it would make sense given the revenue potential of the market. Currently, Macau and Singapore are the largest value drivers of the company, together accounting for more than 80% of its valuation.

The company is heavily dependent on Macau for revenues, and regulation changes in the region have impacted it negatively. At its peak in 2013, Macau’s gaming market had reached a size of $45 billion. However, after stricter regulations imposed by Chinese regulators, revenues started slumping. In 2016, the total amount won by casinos in the region stood at nearly $28 billion. Japan is likely to emerge as a huge market for casinos, with annual revenue estimates ranging from $10 billion to $30 billion.

Top 10 Casino Stocks To Own Right Now: Cross Country Healthcare, Inc.(CCRN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average recommendation of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $14.00.

  • [By Ethan Ryder]

    Cross Country Healthcare (NASDAQ:CCRN) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Wednesday.

  • [By Stephan Byrd]

    American International Group Inc. trimmed its stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 20.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,638 shares of the business services provider’s stock after selling 5,648 shares during the period. American International Group Inc. owned about 0.06% of Cross Country Healthcare worth $252,000 as of its most recent SEC filing.

Top 10 Casino Stocks To Own Right Now: East West Bancorp Inc.(EWBC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on East West Bancorp (EWBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    BB&T Securities LLC lifted its position in East West Bancorp, Inc. (NASDAQ:EWBC) by 2.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,955 shares of the financial services provider’s stock after acquiring an additional 932 shares during the period. BB&T Securities LLC’s holdings in East West Bancorp were worth $2,999,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    FDx Advisors Inc. reduced its position in shares of East West Bancorp, Inc. (NASDAQ:EWBC) by 28.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 20,326 shares of the financial services provider’s stock after selling 8,209 shares during the period. FDx Advisors Inc.’s holdings in East West Bancorp were worth $1,325,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    CB Financial Services (NASDAQ: EWBC) and East West Bancorp (NASDAQ:EWBC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By ]

    Currently, I like People’s Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

  • [By Shane Hupp]

    Commonwealth Equity Services LLC grew its position in shares of East West Bancorp, Inc. (NASDAQ:EWBC) by 17.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,089 shares of the financial services provider’s stock after purchasing an additional 1,189 shares during the period. Commonwealth Equity Services LLC’s holdings in East West Bancorp were worth $505,000 at the end of the most recent quarter.

Top 10 Casino Stocks To Own Right Now: CACI International, Inc.(CACI)

Advisors’ Opinion:

  • [By Rich Smith]

    Let’s start with the story that sparked the rally. Last night, Reuters cited three sources “familiar with the matter” saying that Engility “is exploring a sale” — perhaps to CACI International (NYSE:CACI) or Science Applications International Corp (NYSE:SAIC), two peer defense contractors that are both three to four times larger than Engility.

  • [By Lou Whiteman]

    Kratos Defense & Security Solutions (NASDAQ:KTOS) and CACI International (NYSE:CACI) are two very different companies who rely on a common customer: The U.S. government. Kratos is a onetime wireless-infrastructure vendor who in recent years has focused on microwave electronics, satellite communications, and, most recently, drones. CACI meanwhile was founded in the 1960s by a pair of RAND Corp. alums interested initially in commercializing a software programming language.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CACI INTERNATIONAL INC Common Stock (CACI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lou Whiteman]

    CACI International (NYSE:CACI) has been one of the most aggressive players in the rapidly consolidating government services sector. The company last year fell short in its audacious bid to steal CSRA from the arms of defense titan General Dynamics, but in the quarters since, it has found intriguing ways to deploy its financial firepower.

  • [By Lou Whiteman]

    Those deals clearly have others in the industry scrambling, with CACI International (NYSE:CACI) launching an unsuccessful attempt to outbid General Dynamics for CSRA.

Top 10 Casino Stocks To Own Right Now: IDT Corporation(IDT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    InvestDigital (CURRENCY:IDT) traded 5.9% lower against the U.S. dollar during the one day period ending at 20:00 PM ET on September 8th. During the last week, InvestDigital has traded down 36.1% against the U.S. dollar. InvestDigital has a total market cap of $0.00 and $81,200.00 worth of InvestDigital was traded on exchanges in the last day. One InvestDigital token can now be bought for about $0.0077 or 0.00000125 BTC on exchanges including HADAX and BigONE.

  • [By Stephan Byrd]

    Swisscom (OTCMKTS: SCMWY) and IDT (NYSE:IDT) are both utilities companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Logan Wallace]

    IDT Co. (NYSE:IDT) announced a quarterly dividend on Monday, June 4th, Zacks reports. Investors of record on Tuesday, June 19th will be paid a dividend of 0.09 per share by the utilities provider on Friday, June 29th. This represents a $0.36 annualized dividend and a dividend yield of 5.84%. The ex-dividend date of this dividend is Monday, June 18th.

  • [By Joseph Griffin]

    IDT (NYSE: IDT) and Swisscom (OTCMKTS:SCMWY) are both utilities companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Top 10 Casino Stocks To Own Right Now: Santander Consumer USA Holdings Inc.(SC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Santander Consumer USA Holdings Inc. (NYSE: SC) shares were also up, gaining 14 percent to $17.89 following upbeat quarterly earnings.

    Equities Trading DOWN

  • [By Jordan Wathen]

    Shares of subprime automotive lender Santander Consumer USA Holdings (NYSE:SC) are up by about 16% as of 11:35 a.m. EDT after the company announced earnings that were better than Wall Street expected. It earned $242 million, or $0.67 per diluted share, driven by higher loan originations, falling expenses, and declining provisions for loan losses in the first quarter.

  • [By Lisa Levin]

    Tuesday morning, the financial shares climbed 1.04 percent. Meanwhile, top gainers in the sector included Santander Consumer USA Holdings Inc. (NYSE: SC), up 15 percent, and OTC Markets Group Inc (OTC: OTCM), up 8 percent.

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7

Top 10 Casino Stocks To Own Right Now: Herman Miller, Inc.(MLHR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Herman Miller (MLHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Herman Miller (MLHR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Asit Sharma]

    Herman Miller, Inc.’s (NASDAQ:MLHR) fiscal fourth-quarter 2018 and first-quarter 2019 reports, issued in July and September, have restored the trajectory of company stock: Down as much as 27% this spring, shares have rebounded to a mere 2% loss year to date. Improved order flow and strong organic growth have allayed investor fears over a revenue deceleration. In addition, the iconic office furniture designer and manufacturer has been able to quantify the expected impact of aluminum and steel import tariffs, while presenting credible steps to mitigate their effect. Finally, shareholders appear to approve of the appointment of Andi Owen to the role of CEO. Owen succeeded longtime CEO Brian Walker in August following his retirement. 

Top 10 Casino Stocks To Own Right Now: Royal Dutch Shell PLC(RDS.A)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Royal Dutch Shell plc ADR Class A (NYSE: RDS.A) and Jagged Peak Energy (NYSE:JAG) are both oils/energy companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

  • [By Dustin Parrett]

    Earlier this year, Royal Dutch Shell Plc. (NYSE: RDS.A) spent $217 million to buy a 44% stake in Silicon Ranch Corp., a major U.S. solar developer. Shell is committing $1 billion a year to clean energy investments.

  • [By Max Byerly]

    Royal Dutch Shell (NYSE:RDS.A) and Oasis Petroleum (NYSE:OAS) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Top 10 Casino Stocks To Own Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) released its fiscal second-quarter financial results before the markets opened on Tuesday. The company said that it had $0.57 in earnings per share (EPS) and $384.62 million in revenue, which compares with consensus estimates of $0.41 in EPS and revenue of $384.09 million. In the same period of last year, the retailer said it had EPS of $0.26 and $366.65 million in revenue.

  • [By Alexander Bird]

    Here are this week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
     Axovant Sciences (Nasdaq: AXON) $4.87 150.00%
    American Electric Technologies Inc. (Nasdaq: AETI) $1.56 102.70%
    EDAP TMS SA (Nasdaq: EDAP) $3.44 58.59%
    Conn’s Inc. (Nasdaq: CONN) $2.01 51.99%
    Versartis Inc. (Nasdaq: VSAR) $2.15 48.28%
    Onconova Therapeutics Inc. (Nasdaq: ONTX) $0.54 47.92%
    Ameri Holdings Inc. (Nasdaq: AMRH) $1.21 44.73%
    Westwater Resources Inc. (Nasdaq: WWR) $0.58 36.76%
    Top Ships Inc. (Nasdaq: TOPS) $1.04 35.44%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 30.59%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that these kinds of returns are not guaranteed.

  • [By Chris Lange]

    When Conn’s Inc. (NASDAQ: CONN) reported its fiscal first-quarter financial results before the markets opened on Thursday, the retailer said that it had $0.40 in earnings per share (EPS) and $358.4 million in revenue. Consensus estimates from Thomson Reuters had called for $0.27 in EPS on revenue of $354.84 million. In the same period of last year, Conn’s said it had a net loss of $0.05 per share and $355.83 million in revenue.

Top 10 Casino Stocks To Own Right Now: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Own Right Now: Vanguard Value ETF (VTV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dynamic Advisor Solutions LLC bought a new stake in Vanguard Value ETF (NYSEARCA:VTV) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,421 shares of the company’s stock, valued at approximately $353,000.

Best Warren Buffett Stocks To Buy Right Now

Since 2014 Hershey (NYSE:HSY) has been struggling a lot with its foreign operations. This has been due to the facts that the general business environment has been rather weak in foreign countries where Hershey is operating, that a strong dollar has hurt the sales and especially that the Chinese market has proved to be much more difficult than expected.

One other thing that I am even more worried about is the way the current management at Hershey is using adjusted earnings in its earnings releases. I do not know about the rest of the investors, but at least for me, when management is constantly talking about adjusted earnings instead of actual earnings, it is a warning sign. I can fully understand one-time business costs, such as transactions costs related to a major acquisition. In that type of a situation it is perfectly fine to use adjusted earnings because they give more visibility about the true earnings power of a company. However, when a company starts to constantly categorize regular annual costs as one-time costs, like Hershey is doing with business realignment costs, you should be very worried. In the case of Hershey, I would consider the business realignment costs as regular costs as they have been there for several years. This is a bit like when Warren Buffett is recommending that investors walk away if management is constantly referring to EBIT figures.

Best Warren Buffett Stocks To Buy Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

Best Warren Buffett Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Best Warren Buffett Stocks To Buy Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Best Warren Buffett Stocks To Buy Right Now: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Natural gas just claimed another victory over clean coal, as Southern Co. (NYSE: SO) announced on June 28 it’s converting its failed $7.1 billion clean coal power plant into a natural gas-fired facility.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 2.9% Wednesday and posted a new 52-week low of $45.81 after closing Tuesday at $47.20. The 52-week high is $53.51. Volume was about 5.5 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Wednesday.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.7% Friday and posted a new 52-week low of $44.46 after closing Thursday at $45.25. The 52-week high is $53.51. Volume was over 6 million, about 20% above the daily average of around 4.8 million shares. The company was dropped from Neutral to Sell at Goldman Sachs on Thursday.

Best Warren Buffett Stocks To Buy Right Now: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

Best Warren Buffett Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

stock market

Stocks have thus far avoided another big down day following yesterday’s collapse, but it still feels like there’s another shoe to drop, doesn’t it?

Getty Images

So how will we know that the worst is over? Fundstrat technical analyst Robert Sluymer recommends “watching the downside leader, Energy, for evidence of decelerating,” particularly ExxonMobil (XOM) and Chevron (CVX). He explains:

Beyond the obvious defensive relative rotation underway favoring Bond proxies, Staples and Restaurants at the expense of Cyclicals and Financials, we are monitoring Energy closely. Why? Energy, peaked in relative performance terms in December and has since led Cyclicals lower. While it is premature to suggest an improvement is developing for the sector, the list of names making new multi-week relative lows has not expanded during recent market weakness. Although XOM and CVX are the most defensive names in the sector, relative performance is showing early signs of improving, as both names become tactically. Defensive exposure with an offensive option?

stock market: Madison Square Garden Inc.(MSG)

Advisors’ Opinion:

  • [By Monica Gerson]

    Madison Square Garden Co (NYSE: MSG) is estimated to report a quarterly loss at $0.34 per share on revenue of $325.53 million.

    Gogo Inc (NASDAQ: GOGO) is projected to report a quarterly loss at $0.42 per share on revenue of $137.58 million.

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Meanwhile, Mark Boyar, of The Boyar Value Fund, recommends another household name: Madison Square Garden (MSG). He thinks the Dolan family could take the company private.

stock market: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    You can torture the data many ways, of course, and there were some pharma price increases in the US, but apparently, they were not especially large. What hurt were discounting, especially for Xarelto, a Bayer (OTCPK:BAYRY) oral anticoagulant which JNJ markets in the US; and the diabetes Invokana line.

  • [By SEEKINGALPHA.COM]

    The Regeneron press release in November for its Q3 2017 financial and operating results reaffirmed Eylea’s full year 2017 U.S. net product sales growth of approximately 10% over 2016, which could be about $1 billion. From our model, we see the Q4 total revenues for Eylea, excluding sales outside the United States from Regeneron’s collaborative partner Bayer AG (OTCPK:BAYRY), of $1.2 billion, or a 17% increase year-on-year. REGN stock has a forward P/E ratio of 21.83 as of December 8, 2017, while the current trailing P/E is 34.57.

  • [By Todd Campbell]

    Nektar Therapeutics is working with Bayer AG (NASDAQOTH:BAYRY) on an inhaledversion of Amikacin, an anti-bacterial that if successful in trials could be used alongside standard of care to treat gram-negative pneumonia in intubated and mechanically ventilated patients. If it’s eventually approved in the U.S., Nektar Therapeutics will receive a flat 30% royalty on sales. It’s also working with Bayer on an inhaled powder formulation of Cipro that could be used to treat chronic lung infections in cystic fibrosis patients. Top-line phase 3 results on both drugs should be available this year.

  • [By SEEKINGALPHA.COM]

    This type of spin-off is not uncommon among German companies, as they streamline their portfolios to focus on the where they have more competitive advantages in the long term. For instance, in the recent past, Siemens (OTCPK:SIEGY) has split out Osram (OTC:OSAGY) and Bayer (OTCPK:BAYRY) has performed the spin-off of Covestro (OTCPK:CVXTY), something that Rheinmetall is likely to do in the near future because its auto unit has reached peak margins, and therefore this is the best time to spin-off the business.

  • [By SEEKINGALPHA.COM]

    Rivaroxaban was initially developed by Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ). It later entered an agreement with Bayer (OTCPK:BAYRY) to jointly complete the development process in 2005.

  • [By SEEKINGALPHA.COM]

    A very risky Phase 3 drug for high cholesterol, anacetrapib, is listed and is in Phase 3; but several others of the class have failed, and there’s little reason to expect a success here (but you never know). Finally, a partnered heart failure drug that is also in Phase 3, vericiguat, is partnered with Bayer (OTCPK:BAYRY). This compound failed its primary endpoint in Phase 2. Yet, the partners agreed that there was hope for the highest of the three doses. Thus, I view this drug as a very high risk Phase 3 product. Maybe it will be successful and blockbuster, but it’s no sure thing.

stock market: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) will share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.07 per share and $413.12 million in revenue. Shares were at $6.84 on Fridays close, in a 52-week range of $6.54 to $34.60. The consensus price target is $13.17.

  • [By Lisa Levin]

    Conn's Inc (NASDAQ: CONN) shares were also up, gaining 32 percent to $11.18 after the company reported better-than-expected earnings for its fourth quarter.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Conn’s Inc (NASDAQ: CONN) shares dropped 23 percent to $9.03 as the company reported downbeat quarterly results. Conn’s posted a Q1 loss of $0.31 per share on revenue of $389.1 million.

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

stock market: Leading Brands Inc(LBIX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares dropped 13 percent to $1.99 following Q2 results. Leading Brands posted Q2 EBITDAS of $0.00 per share, compared to $0.09 per share during the same period last year.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares shot up 66 percent to $2.49 following Q1 results. Leading Brands reported Q1 earnings of $0.10 per share on revenue of $3.033 million.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares were also up, gaining 145 percent to $3.31 on no formal news from company. The stock rallied 215 percent over Tuesday and Wednesday of this week amid trader speculation stock could be sympathy play on move higher in Helios & Matheson. However, Leading Brands shares sold off 27 percent on Thursday.

stock market: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

Top 10 Value Stocks To Invest In Right Now

Smart investors always have a plan to prepare for a stock market crash. In fact, stock market crashes only devastating because most investors are rarely prepared for a major pullback.

Plus, the timing of stock market crashes is impossible to predict with certainty…

The stock market crash of 1929 wiped out 86% of the value of the Dow in just three years. But before the crash, the Dow had gained over 300% during the 1920s and economists were predicting that stocks could only rise. Famed economist Irving Fisher claimed stocks had reached a “permanently high plateau” in 1929, just over a month before the crash.

Top 10 Value Stocks To Invest In Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Electronics Stores: This industry moved up 1.16% by 10:15 am. The top performer in this industry was Conns (NASDAQ: CONN), which gained 1.3%. Conns’ PEG ratio is 0.87.

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co now outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Chris Lange]

    Conn’s Inc. (NASDAQ: CONN) will share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.07 per share and $413.12 million in revenue. Shares were at $6.84 on Fridays close, in a 52-week range of $6.54 to $34.60. The consensus price target is $13.17.

Top 10 Value Stocks To Invest In Right Now: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Matt Hogan]

    Skechers USA Inc (NYSE: SKX) is expected to report earnings on Thursday after the market closes. The footwear company has generally traded lower over the last eight quarters in the face of decelerating revenue growth. The stock had been gaining some momentum in the early part of the year until Susquehanna's Sam Poser downgraded the company to a negative rating on March 29th. Poser warned that domestic wholesale growth would fall short of investor expectations and the stock has since fallen 15 percent.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Brian Withers] When the number one company in comfort-casual footwear,Skechers (NYSE:SKX) announced earnings last month, the headlines highlighted the first ever $1 billion quarter for the company. It seems investors weren’t impressed, though, as the stock continues to lag behind the market and has missed a nice run up over the past year.

Top 10 Value Stocks To Invest In Right Now: NETGEAR, Inc.(NTGR)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares ofNetgear(NASDAQ:NTGR)climbed 30% in 2016,according to data from S&P Global Market Intelligence, as the networking hardware specialist repeatedly exceeded quarterly expectations.

Top 10 Value Stocks To Invest In Right Now: Pentair plc.(PNR)

Advisors’ Opinion:

  • [By Lee Jackson]

    Pentair PLC(NYSE: PNR) had a major holder and director of the company buying more shares last week. Trian Fund purchased 863,000 shares of this diversified industrial manufacturing company at prices that ranged from $65.13 to $65.41 apiece. The total for the trade was posted at a huge $56 million. The stock closed Friday at $67.11, so the purchase appears to be well timed. The52-week trading range is $53.80 to $69.03, and the Wall Street consensus price objective is $67.50.

  • [By Ben Levisohn]

    RBC’s Deane Dray and team worry that valuations of industrial stocks like General Electric (GE), Danaher (DHR), Honeywell International (HON), Ingersoll-Rand (IR) and Pentair (PNR) have gotten ahead of themselves and recommend a “barbell strategy” when playing the sector. They explain:

  • [By William Patalon III]

    Water-equipment company – and Private Briefing favorite – Pentair PLC (NYSE: PNR) left investors with mixed feelings after reported its earnings on Tuesday.

  • [By Ben Levisohn]

    While the direct revenue exposure to the UK is relatively small across our coverage (aside fromTyco and Idex), the potential impact from Brexit is much more widespread across the continent and the world. The impact should be most negative for our companies with larger industrial exposure to Europe, just as we have begun to hear incrementally positive commentary regarding Europe.Idex andTyco have some of the highest direct exposures to UK and Europe but Tyco’s business should be relatively more stable and in any case theJohnson Controls (JCI) synergies loom large. Eaton (ETN) and Emerson Electric, though with slightly smaller exposure, are more involved with industrial spending.Danaher andHoneywell have high revenue exposure, but we believe that their more benign end market exposure should mitigate some of the negative consequences they face. We rate Allegion (ALLE), Danaher, Dover (DOV), Fortive (FTV), Honeywell, Ingersoll-Rand (IR), Pentair (PNR) andTyco Outperform; Emerson Electric, Eaton, General Electric (GE),Idex and 3M (MMM) Market-Perform; Rockwell Automation (ROK) Underperform.

Top 10 Value Stocks To Invest In Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

Top 10 Value Stocks To Invest In Right Now: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, utilities shares were relative laggards, down on the day by about 0.32 percent. Meanwhile, top losers in the sector included Genie Energy Ltd (NYSE: GNE), down 3 percent, and SCANA Corporation (NYSE: SCG), down 3 percent.

  • [By Lisa Levin]

    In trading on Monday, utilities shares were relative laggards, down on the day by about 0.43 percent. Meanwhile, top losers in the sector included SCANA Corporation (NYSE: SCG), down 2 percent, and FirstEnergy Corp. (NYSE: FE), down 2 percent.

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Atlantic Power Corp (NYSE: AT), down 2 percent, and SCANA Corporation (NYSE: SCG) down 1 percent.

Top 10 Value Stocks To Invest In Right Now: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)

Top 10 Value Stocks To Invest In Right Now: Orion Marine Group Inc(ORN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows small caps Great Lakes Dredge & Dock Corporation andLayne Christensen Company (NASDAQ: LAYN) underperforming, but possibly recovering while Orion Group Holdings (NYSE: ORN) had a clear reversal early last year:

Top 10 Value Stocks To Invest In Right Now: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:

  • [By Peter Graham]

    Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.

Top 10 Value Stocks To Invest In Right Now: Carlsberg A/S (CABGY)

Advisors’ Opinion:

  • [By Mark Fritz]

    Price Target: $124.

    Heineken N.V. (ADR) (OTC: HINKY): Hold.
    Price Target: 82.30 euros.

    Carlsberg A/S (ADR) (OTC: CABGY): Hold.
    Price Target: 652 krones.

    Distillers